Allegra-d Allergy And Congestion Tablet, Film Coated, Extended Release
Product Images NDC 41167-4310

1 FDA label image from Chattem, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Allegra-d Allergy And Congestion (NDC 41167-4310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chattem, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ndc 41167-4310-6allegra-d®allergy &congestion 12hrfexofenadine Hci 60 mg/antihistaminepseudoephedrine Hci 120 mg/nasal Decongestantextended Release Tablets30 Tablets (Allegra D Allergy And Congestion 12 Hr 01)

Ndc 41167-4310-6allegra-d®allergy &congestion 12hrfexofenadine Hci 60 mg/antihistaminepseudoephedrine Hci 120 mg/nasal Decongestantextended Release Tablets30 Tablets (Allegra D Allergy And Congestion 12 Hr 01)
Packaging label for Allegra-D Allergy and Congestion 12 HR extended release tablets. Each tablet contains fexofenadine HCl 60 mg (antihistamine) and pseudoephedrine HCl 120 mg (nasal decongestant). The orange and purple box holds 30 film-coated tablets, produced by Chattem, Inc. The label emphasizes non-drowsy, indoor/outdoor relief of nasal and sinus congestion and allergy symptoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.